Abstract
Background: Encapsulated papillary carcinoma of the breast is rare, making difficult diagnosis and resulting in patients undergoing excision biopsy before definitive surgery. Evidence-based guidelines are sparse. We would like to further elucidate the clinicopathological, treatment and survival outcomes. Materials and Methods: 54 patients identified, with a median follow up duration of 48 months. Patients' demographics, radiological and clinicopathological characteristics, treatment, adjuvant therapies as well as survival data were analysed. Results: 18 (33.3%) cases were pure EPC, 12 (22.2%) were EPC associated with ductal carcinoma in situ (DCIS) and 24 (44.4%) cases had concurrent invasive ductal carcinoma. EPCs were more likely to present as a solid-cystic mass on sonography (63.8%), regular-shaped (oval or round) (97.9%), lack spiculations (95.7%) and lack suspicious microcalcifications (95.6%). Median tumour size was largest in the EPC with IDC group (18.5 mm). 2 patients developed loco-regional recurrence. Overall survival is good for EPCs of all subtypes. Conclusion: EPC is a rare tumour with excellent prognosis.
| Original language | English |
|---|---|
| Pages (from-to) | 11408-11416 |
| Number of pages | 9 |
| Journal | Cancer Medicine |
| Volume | 12 |
| Issue number | 10 |
| DOIs | |
| Publication status | Published - May 2023 |
| Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2023 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- breast
- encapsulated
- papillary
Fingerprint
Dive into the research topics of 'Encapsulated papillary carcinoma of the breast: An institutional case series and literature review'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver